Consistent safety and tolerability of Valtoco® (diazepam nasal spray) in relationship to usage frequency in patients with seizure clusters: Interim results from a phase 3, long‐term, open‐label, repeat‐dose safety study
Sign Up to like & getrecommendations! Published in 2021 at "Epilepsia Open"
DOI: 10.1002/epi4.12494
Abstract: Need for rescue therapy differs among patients with seizure clusters. Diazepam nasal spray is approved to treat seizure clusters in patients with epilepsy ≥6 years of age. This analysis used interim data from a phase… read more here.
Keywords: patients seizure; diazepam nasal; safety; seizure clusters ... See more keywords
Elevated serum free IL-18 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders
Sign Up to like & getrecommendations! Published in 2022 at "Lupus"
DOI: 10.1177/09612033211069853
Abstract: Background Since dysregulation of total Interleukin (IL)-18 and IL-18 binding protein (IL-18BP) may participate in systemic lupus erythematosus (SLE) and contribute to the occurrence of non-autoimmune epilepsy, the aim of the current work is to… read more here.
Keywords: neuropsychiatric systemic; patients seizure; systemic lupus; lupus erythematosus ... See more keywords
SCN2A-Related Epilepsy: The Phenotypic Spectrum, Treatment and Prognosis
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Molecular Neuroscience"
DOI: 10.3389/fnmol.2022.809951
Abstract: Objective The aim of this study was to analyze the phenotypic spectrum, treatment, and prognosis of 72 Chinese children with SCN2A variants. Methods The SCN2A variants were detected by next-generation sequencing. All patients were followed… read more here.
Keywords: epilepsy; patients seizure; phenotypic spectrum; scn2a variants ... See more keywords